710 related articles for article (PubMed ID: 26195123)
1. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.
Elmunzer BJ; Scheiman JM; Lehman GA; Chak A; Mosler P; Higgins PD; Hayward RA; Romagnuolo J; Elta GH; Sherman S; Waljee AK; Repaka A; Atkinson MR; Cote GA; Kwon RS; McHenry L; Piraka CR; Wamsteker EJ; Watkins JL; Korsnes SJ; Schmidt SE; Turner SM; Nicholson S; Fogel EL;
N Engl J Med; 2012 Apr; 366(15):1414-22. PubMed ID: 22494121
[TBL] [Abstract][Full Text] [Related]
3. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial.
Hosseini M; Shalchiantabrizi P; Yektaroudy K; Dadgarmoghaddam M; Salari M
Arch Iran Med; 2016 Aug; 19(8):538-43. PubMed ID: 27544361
[TBL] [Abstract][Full Text] [Related]
5. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
6. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
7. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes].
Montaño Loza A; Rodríguez Lomelí X; García Correa JE; Dávalos Cobián C; Cervantes Guevara G; Medrano Muñoz F; Fuentes Orozco C; González Ojeda A
Rev Esp Enferm Dig; 2007 Jun; 99(6):330-6. PubMed ID: 17883296
[TBL] [Abstract][Full Text] [Related]
9. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin].
Montaño Loza A; García Correa J; González Ojeda A; Fuentes Orozco C; Dávalos Cobián C; Rodríguez Lomelí X
Rev Gastroenterol Mex; 2006; 71(3):262-8. PubMed ID: 17140047
[TBL] [Abstract][Full Text] [Related]
11. [Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis].
Döbrönte Z; Toldy E; Márk L; Sarang K; Lakner L
Orv Hetil; 2012 Jun; 153(25):990-6. PubMed ID: 22714033
[TBL] [Abstract][Full Text] [Related]
12. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
Nicolás-Pérez D; Castilla-Rodríguez I; Gimeno-García AZ; Romero-García R; Núñez-Díaz V; Quintero E
Pancreas; 2015 Mar; 44(2):204-10. PubMed ID: 25406954
[TBL] [Abstract][Full Text] [Related]
13. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
[No Abstract] [Full Text] [Related]
15. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.
Siddiqui AA; Patel D; Kaplan J; Zabolotsky AH; Loren D; Kowalski T; Ghumman SS; Adler DG; Munigal S; Hayat U; Eloubeidi MA
Dig Dis Sci; 2015 Aug; 60(8):2509-15. PubMed ID: 25868629
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M
Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
18. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
Wan J; Ren Y; Zhu Z; Xia L; Lu N
BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
[TBL] [Abstract][Full Text] [Related]
19. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.
Shi N; Deng L; Altaf K; Huang W; Xue P; Xia Q
Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198
[TBL] [Abstract][Full Text] [Related]
20. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
Luo H; Zhao L; Leung J; Zhang R; Liu Z; Wang X; Wang B; Nie Z; Lei T; Li X; Zhou W; Zhang L; Wang Q; Li M; Zhou Y; Liu Q; Sun H; Wang Z; Liang S; Guo X; Tao Q; Wu K; Pan Y; Guo X; Fan D
Lancet; 2016 Jun; 387(10035):2293-2301. PubMed ID: 27133971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
